EQUITY RESEARCH MEMO

Opis Research

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)50/100

Opis Research is a data-driven, quality-focused clinical Contract Research Organization (CRO) headquartered in Milan, Italy. Founded in 2015, the company specializes in neuroscience and oncology, offering services for both interventional and non-interventional multi-country trials. With a team experienced in new-generation drugs, advanced therapeutic procedures, and biologic treatments, Opis collaborates with international sponsors to bring innovative therapies to market. Despite operating at a pre-clinical stage, the company has established a strong reputation for robust data management and regulatory compliance, positioning itself as a reliable partner in complex clinical research environments.

Upcoming Catalysts (preview)

  • Q3 2026Major contract win with a top pharmaceutical company60% success
  • Q4 2026Expansion of service offerings into new therapeutic areas50% success
  • TBDStrategic partnership with a clinical trial technology provider40% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)